Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.
The word "acute" in acute myelogenous leukemia denotes the disease's rapid progression. It's called myelogenous (my-uh-LOHJ-uh-nus) leukemia because it affects a group of white blood cells called the myeloid cells, which normally develop into the various types of mature blood cells, such as red blood cells, white blood cells and platelets.
Acute myelogenous leukemia is also known as acute myeloid leukemia, acute myeloblastic leukemia, acute granulocytic leukemia and acute nonlymphocytic leukemia.
Sept. 12, 2015
- Niederhuber JE, et al., eds. Acute leukemias in adults. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed March 18, 2015.
- Hoffman R, et al. Clinical manifestations and treatment of acute myelogenous leukemia. In: Hematology: Basic Principles and Practice. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2013. http://www.clinicalkey.com. Accessed March 18, 2015.
- Adult acute myeloid leukemia treatment (PDQ). National Cancer Institute. http://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq. Accessed May 21, 2015.
- Leukemia — acute myeloid — AML. Cancer.Net. http://www.cancer.net/cancer-types/leukemia-acute-myeloid-aml/view-all. Accessed May 21, 2015.
- Integrative medicine & complementary and alternative therapies as part of blood cancer care. Leukemia & Lymphoma Society. http://www.lls.org/#/resourcecenter/freeeducationmaterials/treatment/integrativemedandcam. Accessed March 18, 2015.
- Cook AJ. Decision Support System. Mayo Clinic, Rochester, Minn. March 18, 2015.